SANJIVINPharmaceuticals
Sanjivani Paranteral Ltd — Profit & Loss Statement
₹132.75
-4.83%
Sanjivani Paranteral Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | -8636.64 | 24039.45 | — |
| Tax Rate For Calcs | 0.22 | 0.19 | 0.09 | 0.01 | — |
| Normalized EBITDA | 11.57 Cr | 8.76 Cr | 6.07 Cr | 5.47 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 8.09 Cr | 6.17 Cr | 4.51 Cr | 4.85 Cr | — |
| Reconciled Depreciation | 0.62 Cr | 0.93 Cr | 0.89 Cr | 0.88 Cr | — |
| Reconciled Cost Of Revenue | 40.48 Cr | 28.48 Cr | 21.82 Cr | 15.24 Cr | — |
| EBITDA | 11.57 Cr | 8.76 Cr | 6.06 Cr | 5.84 Cr | — |
| EBIT | 10.95 Cr | 7.83 Cr | 5.17 Cr | 4.96 Cr | — |
| Net Interest Income | -0.59 Cr | -0.25 Cr | -0.35 Cr | -0.21 Cr | — |
| Interest Expense | 0.59 Cr | 0.25 Cr | 0.23 Cr | 0.08 Cr | — |
| Normalized Income | 8.09 Cr | 6.17 Cr | 4.52 Cr | 4.48 Cr | — |
| Net Income From Continuing And Discontinued Operation | 8.09 Cr | 6.17 Cr | 4.51 Cr | 4.85 Cr | — |
| Total Expenses | 60.37 Cr | 47.10 Cr | 30.44 Cr | 25.89 Cr | — |
| Diluted NI Availto Com Stockholders | 8.09 Cr | 6.17 Cr | 4.51 Cr | 4.85 Cr | — |
| Net Income Common Stockholders | 8.09 Cr | 6.17 Cr | 4.51 Cr | 4.85 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 8.09 Cr | 6.17 Cr | 4.51 Cr | 4.85 Cr | — |
| Net Income Including Noncontrolling Interests | 8.09 Cr | 6.17 Cr | 4.51 Cr | 4.85 Cr | — |
| Net Income Continuous Operations | 8.09 Cr | 6.17 Cr | 4.51 Cr | 4.85 Cr | — |
| Tax Provision | 2.26 Cr | 1.41 Cr | 0.43 Cr | 0.03 Cr | — |
| Pretax Income | 10.35 Cr | 7.57 Cr | 4.94 Cr | 4.88 Cr | — |
| Other Non Operating Income Expenses | 1.22 Cr | 0.52 Cr | 92508.00 | 71198.00 | — |
| Net Non Operating Interest Income Expense | -0.59 Cr | -0.25 Cr | -0.35 Cr | -0.21 Cr | — |
| Interest Expense Non Operating | 0.59 Cr | 0.25 Cr | 0.23 Cr | 0.08 Cr | — |
| Operating Income | 9.73 Cr | 7.31 Cr | 4.80 Cr | 4.48 Cr | — |
| Operating Expense | 19.88 Cr | 18.62 Cr | 8.62 Cr | 10.65 Cr | — |
| Other Operating Expenses | 12.77 Cr | 13.59 Cr | -0.25 Cr | 0.84 Cr | — |
| Depreciation And Amortization In Income Statement | 0.62 Cr | 0.93 Cr | 0.89 Cr | 0.88 Cr | — |
| Depreciation Income Statement | 0.62 Cr | 0.93 Cr | 0.89 Cr | 0.88 Cr | — |
| Gross Profit | 29.61 Cr | 25.93 Cr | 13.42 Cr | 15.14 Cr | — |
| Cost Of Revenue | 40.48 Cr | 28.48 Cr | 21.82 Cr | 15.24 Cr | — |
| Total Revenue | 70.10 Cr | 54.41 Cr | 35.24 Cr | 30.38 Cr | — |
| Operating Revenue | 70.10 Cr | 54.41 Cr | 35.24 Cr | 30.38 Cr | — |
| Total Unusual Items | — | -0.15 Cr | -98664.00 | 0.36 Cr | -1.23 Cr |
| Total Unusual Items Excluding Goodwill | — | -0.15 Cr | -98664.00 | 0.36 Cr | -1.23 Cr |
| Interest Income | — | 0.03 Cr | 73963.00 | 41544.00 | 0.02 Cr |
| Rent Expense Supplemental | — | 0.52 Cr | 0.37 Cr | 0.21 Cr | 0.19 Cr |
| Diluted Average Shares | — | 1.17 Cr | 1.00 Cr | 1.00 Cr | 0.85 Cr |
| Basic Average Shares | — | 1.17 Cr | 1.00 Cr | 1.00 Cr | 0.85 Cr |
| Diluted EPS | — | 5.28 | 4.51 | 4.85 | 1.67 |
| Basic EPS | — | 5.28 | 4.51 | 4.85 | 1.67 |
| Special Income Charges | — | -0.15 Cr | -98664.00 | 0.36 Cr | -1.23 Cr |
| Write Off | — | 0.15 Cr | 0.00 | -0.36 Cr | 1.23 Cr |
| Total Other Finance Cost | — | 0.13 Cr | 0.13 Cr | 0.13 Cr | 0.12 Cr |
| Interest Income Non Operating | — | 0.03 Cr | 73963.00 | 41544.00 | 0.02 Cr |
| Research And Development | — | 0.06 Cr | 0.00 | — | — |
| Selling General And Administration | — | 8.57 Cr | 4.59 Cr | 5.88 Cr | 2.39 Cr |
| Selling And Marketing Expense | — | 4.96 Cr | 2.62 Cr | 4.47 Cr | 1.69 Cr |
| General And Administrative Expense | — | 3.61 Cr | 1.97 Cr | 1.41 Cr | 0.69 Cr |
| Rent And Landing Fees | — | 0.52 Cr | 0.37 Cr | 0.21 Cr | 0.19 Cr |
| Other Special Charges | — | — | 98664.00 | — | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Sanjivani Paranteral Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.